Abstract
Primary cardiac lymphomas (PCLs) are a rare clinical entity, in which treatment guidelines remain to be established. Rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (R-EPOCH) has been proposed, given that it involves a continuous infusion of anthracycline, reducing the risk of a cardiotoxicity and therefore the theoretical risk of perforation. However, the literature on this method of treatment is scarce. Herein, we present a unique case of a 75-year-old male, diagnosed with primary cardiac diffuse large B-cell lymphoma (DLBCL) with relatively unusual involvement of the coronary sinus, treated first with one cycle of R-EPOCH, followed by three cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) to reduce said risk. To our knowledge, this is one of two cases, in which a patient with PCL was treated this way.
Similar content being viewed by others
Data availability
Not applicable.
References
Tyebally S, Chen D, Bhattacharyya S et al (2020) Cardiac tumors: JACC cardiooncology state-of-the-art review. JACC CardioOncol Jun 2(2):293–311. https://doi.org/10.1016/j.jaccao.2020.05.009
Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A (2010) Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials. BMC Cancer. /06/29 2010;10(1):337. https://doi.org/10.1186/1471-2407-10-337
Maleszewski JJ, Basso C, Bois MC et al (2022) The 2021 WHO classification of tumors of the heart. J Thorac Oncol Apr 17(4):510–518. https://doi.org/10.1016/j.jtho.2021.10.021
Petrich A, Cho SI, Billett H (2011) Primary cardiac lymphoma. Cancer 117(3):581–589. https://doi.org/10.1002/cncr.25444
Suda T, Ohmizo T, Hayashi T, Kobayashi M (2020) Primary cardiac lymphoma in patients with chronic hepatitis C infection. Eur Heart J Case Rep Dec 4(6):1. https://doi.org/10.1093/ehjcr/ytaa419
Kassab J, Gebrael G, Chedid El Helou M et al (2023) Case report: primary cardiac lymphoma manifesting as superior vena cava syndrome. Front Cardiovasc Med 10:1257734. https://doi.org/10.3389/fcvm.2023.1257734
Ellen S, Emma H (2023) Primary cardiac lymphoma: a case report. Eur Heart J - Case Rep 7(4). https://doi.org/10.1093/ehjcr/ytad175
Chia AXF, Zhao Z, Lim SL (2019) Primary cardiac lymphoma. BMJ Case Rep Dec 2(12). https://doi.org/10.1136/bcr-2019-230468
Rogers SC, O’Connor OA, Granati G, Yaddanapudi K (2016) The first case of primary cardiac lymphoma, diffuse large B-cell type, successfully treated with EPOCH-R. Blood 128(22):5418–5418. https://doi.org/10.1182/blood.V128.22.5418.5418
Thiagaraj A, Kalamkar P, Rahman R, Farah V, Poornima I (2018) An unprecedented case report of primary cardiac lymphoma exclusive to left ventricle: a diagnostic and therapeutic challenge. Eur Heart J Case Rep Jun 2(2):yty029. https://doi.org/10.1093/ehjcr/yty029
Anand K, Pingali SR, Trachtenberg B, Iyer SP (2019) Complete response to R-EPOCH in primary cardiac lymphoma. Case Rep Hematol 2019:7690430. https://doi.org/10.1155/2019/7690430
O’Mahony D, Peikarz RL, Bandettini WP, Arai AE, Wilson WH, Bates SE (2008) Cardiac involvement with lymphoma: a review of the literature. Clin Lymphoma Myeloma Aug 8(4):249–252. https://doi.org/10.3816/CLM.2008.n.034
Farhoud N, Farhoud H, Deutsch JM (2023) Primary cardiac lymphoma in a young and immunocompetent patient diagnosed by percutaneous transvenous biopsy. Am J Cardiol Aug 15:201:139–141. https://doi.org/10.1016/j.amjcard.2023.05.067
Dhorepatil A, Modi V, Kassi M, Chamsi-Pasha MAR, Ewton A, Allen D, Mallah MHA (2023) Insidious Mass within a sinus. Methodist Debakey Cardiovasc J 19(1):92–95. https://doi.org/10.14797/mdcvj.1316
Funding
No funding was received to assist with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
A.R. wrote the main manuscript of the text. S.S. provided guidance to A.R. and reviewed/revised the manuscript critically.
Corresponding author
Ethics declarations
Ethical approval
This manuscript was prepared in accordance with our institutions ethics policy. Patient identifiers have been redacted.
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rezvani, A., Shah, S. Treatment of primary cardiac diffuse large B-cell lymphoma involving the coronary sinus with R-EPOCH: a case report and literature review. Ann Hematol (2024). https://doi.org/10.1007/s00277-024-05793-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00277-024-05793-x